Abeona Therapeutics (ABEO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.74.
- Abeona Therapeutics' Equity Ratio rose 9521.18% to 0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74, marking a year-over-year increase of 9521.18%. This contributed to the annual value of 0.4 for FY2024, which is 7449.24% up from last year.
- Latest data reveals that Abeona Therapeutics reported Equity Ratio of 0.74 as of Q3 2025, which was up 9521.18% from 0.66 recorded in Q2 2025.
- Abeona Therapeutics' Equity Ratio's 5-year high stood at 0.74 during Q3 2025, with a 5-year trough of 0.12 in Q1 2024.
- Its 5-year average for Equity Ratio is 0.42, with a median of 0.4 in 2024.
- Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 13378.48% in 2024, then soared by 45101.98% in 2025.
- Quarter analysis of 5 years shows Abeona Therapeutics' Equity Ratio stood at 0.53 in 2021, then decreased by 21.72% to 0.42 in 2022, then crashed by 44.41% to 0.23 in 2023, then surged by 74.49% to 0.4 in 2024, then skyrocketed by 83.31% to 0.74 in 2025.
- Its last three reported values are 0.74 in Q3 2025, 0.66 for Q2 2025, and 0.42 during Q1 2025.